Within hours of Hims & Hers announcing its semaglutide pill, the FDA launched a crackdown on non-approved GLP-1 drugs specifically mentioning Hims & Hers, among other compounders
Alongside weight reduction, the drug has been shown to improve metabolic health markers, including blood sugar control, hemoglobin A1c, blood pressure, and insulin sensitivity
I am not an athlete and I never will be
Approximately 20% of tirzepatide patients experience nausea during the dose escalation period
PlexusDx recommends that patients report persistent dizziness to their healthcare provider before self-adjusting dose or discontinuing therapy
once you step outside of a regulated pharmacy, it becomes nearly impossible for a consumer to distinguish a legitimate unlicensed import from a dangerous counterfeit produced in a clandestine lab," she said